PDE10A Inhibition Disrupts Lipid Droplet Formation and Sensitizes Macrophages to Ferroptosis after LPS treatment

Bradford C Berk1,2, Jinmin Zhang3, Chia George Hsu3,4

  • 1Department of Medicine, Aab Cardiovascular Research Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.

Insights

Inflammation, triggered by lipopolysaccharide (LPS), protects macrophages from ferroptosis, a cell death pathway. This resistance is linked to lipid droplet accumulation, offering new therapeutic targets for inflammatory diseases.

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • Ferroptosis, an iron-dependent cell death, is implicated in diseases.
  • The role of macrophage activation in ferroptosis remains largely unknown.

Purpose of the Study:

  • To investigate how macrophage activation influences ferroptosis susceptibility.
  • To identify mechanisms underlying ferroptosis resistance in activated macrophages.

Main Methods:

  • Utilized bone marrow-derived macrophages (BMDMs) and various inflammatory stimuli (LPS, Zymosan A, TNF-α).
  • Assessed ferroptosis using morphological changes, lactate dehydrogenase (LDH) release, and real-time cell death assays.
  • Investigated the role of lipid droplet accumulation and Nrf2 signaling pathways.
  • Examined the effect of PDE10A inhibition on ferroptosis.

Main Results:

  • LPS priming significantly enhanced resistance to ferroptosis in BMDMs.
  • This resistance was associated with increased lipid droplet accumulation, not Nrf2 activation.
  • Zymosan A and TNF-α also conferred ferroptosis resistance.
  • PDE10A inhibition reversed LPS-induced ferroptosis resistance and reduced lipid droplets.
  • Ferroptosis resistance was specific to macrophages.

Conclusions:

  • Macrophage activation by inflammatory signals like LPS confers resistance to ferroptosis.
  • Lipid droplet accumulation is a key mechanism driving this resistance.
  • Targeting PDE10A may represent a therapeutic strategy for ferroptosis-related inflammatory conditions.